Novartis AG
IMMUNOSUPPRESSANT FORMULATION
Last updated:
Abstract:
The present invention concerns a dosage form, preferably for immediate release, comprising siponimod, a moisture-protective-agent and further pharmaceutical excipients and methods for producing said dosage form.
Status:
Application
Type:
Utility
Filling date:
4 Feb 2021
Issue date:
3 Jun 2021